Carlo Boutton
Inventor
Stats
- 7 US patents issued
- 56 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 7 US Patents Issued
- 56 US Applications Filed
- 171 Total Citation Count
- Feb 16, 2024 Most Recent Filing
- Nov 3, 2000 Earliest Filing
Work History
Patent Owner | Applications Filed | Year |
---|---|---|
NOVARTIS AG | 2
1 1 | 2013
2015 2017 |
Lonza Biologies PLC | 1
| 2010
|
ABLYNX N.V. | 2
3 1 1 3 2 4 1 2 | 2008
2009 2010 2011 2012 2013 2015 2016 2017 |
MERCK SHARP & DOHME CORP. | 3
| 2016
|
LONZA BIOLOGICS PLC | 1
2 1 2 | 2000
2010 2011 2012 |
Inventor Addresses
Address | Duration |
---|---|
Gent, BE | Apr 25, 24 - Apr 25, 24 |
Heusden, BL | Feb 10, 22 - Feb 10, 22 |
WIELSBEKE, BE | May 21, 20 - May 21, 20 |
Wielsbeke, BE | Nov 12, 09 - Dec 31, 24 |
Zwevegem, BE | Jun 09, 11 - Oct 29, 13 |
Technology Profile
Technology | Matters | |
---|---|---|
A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 28 |
A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 5 |
C07K: | PEPTIDES | 52 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
12180268 | 2024 | Immunoglobulin variable domains | 0 |
2024/0415,974 | 2024 | PROTEIN-BASED CONJUGATION CARRIERS | 0 |
2024/0368,250 | 2024 | POLYPEPTIDES BINDING TO THE NEONATAL FC RECEPTOR | 0 |
2024/0343,823 | 2024 | POLYPEPTIDES COMPRISING IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS TARGETING GLYPICAN-3 AND T CELL RECEPTOR | 0 |
12006352 | 2024 | Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.